BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its board of directors. Jason Lewis has resigned as a director of the Company. We thank him for his three years of service as a director. Mr. Lewis will continue in his role as the Company’s Senior Vice President, Business Development. In conjunction with the resignation o
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
- Loading stock data...
- The Cannabist Company Highlights Product Innovation with Launch of Unique Fast-Acting and Longer-Lasting Layered Edibles
- Tenet to Participate in Barclays 26th Annual Global Healthcare Conference
- IGC Pharma Reports Third Quarter Fiscal 2024 Results
- Brown-Forman Announces Sale of Cooperage in Alabama
- American Weed Co. is First-Ever Cannabis Brand to Headline Sponsor Major U.S. Music Festival